Highlights,Institutional investments in Arcus Biosciences have seen recent increases.,The company focuses on developing ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcus Biosciences (RCUS – Research Report), ...

Bulltick has selected Arcus Partners’ Finity360 solution to enhance its middle-office operations. This strategic move ...

Arcus Capital Partners LLC increased its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 21.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...

Research analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Arcus Biosciences in a research note issued on Tuesday, March 11th. Cantor Fitzgerald analyst ...

A fund managed by Arcus Infrastructure Partners has acquired a service vessel provider for the salmon farming industry in ...

AKVA group ASA (“AKVA”) has signed an agreement to sell its 21.55% ownership in Abyss Group AS (“Abyss”) to Arcus Infrastructure Partners LLP. AKVA's net proceeds from the sale of approx. MNOK 140 ...

Arcus Infrastructure Partners has acquired Abyss, a specialist service vessel provider supporting the salmon farming industry in Norway and Iceland.

Arcus Biosciences (NYSE: RCUS) presented its strategic pipeline updates at the Barclays 27th Annual Global Healthcare Conference on Thursday, 13 March 2025. The company, led by CEO Terry Rosen and ...